ATE204871T1 - 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente - Google Patents

5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente

Info

Publication number
ATE204871T1
ATE204871T1 AT97905478T AT97905478T ATE204871T1 AT E204871 T1 ATE204871 T1 AT E204871T1 AT 97905478 T AT97905478 T AT 97905478T AT 97905478 T AT97905478 T AT 97905478T AT E204871 T1 ATE204871 T1 AT E204871T1
Authority
AT
Austria
Prior art keywords
derivatives
eüä1
dihydrodibenz
oxazepine
dihydro
Prior art date
Application number
AT97905478T
Other languages
English (en)
Inventor
Yuji Tanaka
Keiji Misumi
Yoshinari Kawakami
Masahiko Moriguchi
Kazuyoshi Takahashi
Hiroki Okamoto
Toshiaki Kamisaki
Kimihiro Inoue
Makoto Sato
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Application granted granted Critical
Publication of ATE204871T1 publication Critical patent/ATE204871T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT97905478T 1996-03-11 1997-03-11 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente ATE204871T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8310496 1996-03-11
PCT/JP1997/000754 WO1997033885A1 (en) 1996-03-11 1997-03-11 5,11-DIHYDRODIBENZ[b,e][1,4]OXAZEPINE DERIVATIVES AND DRUG COMPOSITIONS CONTAING THE DERIVATIVES

Publications (1)

Publication Number Publication Date
ATE204871T1 true ATE204871T1 (de) 2001-09-15

Family

ID=13792896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905478T ATE204871T1 (de) 1996-03-11 1997-03-11 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente

Country Status (16)

Country Link
US (2) US6127361A (de)
EP (1) EP0889043B1 (de)
JP (1) JP3127469B2 (de)
KR (1) KR100344331B1 (de)
CN (1) CN1085209C (de)
AT (1) ATE204871T1 (de)
AU (1) AU704521B2 (de)
BR (1) BR9707962A (de)
CA (1) CA2261271C (de)
DE (1) DE69706406T2 (de)
ES (1) ES2159843T3 (de)
NO (1) NO310976B1 (de)
PT (1) PT889043E (de)
TW (1) TW479057B (de)
WO (1) WO1997033885A1 (de)
ZA (1) ZA972038B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU740878B2 (en) 1997-09-10 2001-11-15 Ajinomoto Co., Inc. 5,11-dihydrodibenz(b,e)(1,4)oxazepine derivatives and medicinal composition containing the same
EP1142884A4 (de) 1999-01-08 2002-06-12 Ajinomoto Kk Oxazepin derivate und drogen die diese enthalten
EP1219611A4 (de) * 1999-09-03 2003-03-19 Ajinomoto Kk Neuartige prozesse zur herstellung von oxazepin-derivaten
AU2001217359A1 (en) * 2000-12-11 2002-06-24 Ajinomoto Co., Inc. Novel crystals of oxazepine derivatives and process for the production thereof
EP1403258A4 (de) * 2001-05-30 2005-06-08 Ajinomoto Kk Dihydrodiaryloxazepinderivat und eine das derivat enthaltende medizinische zusammensetzung
JP2005343791A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc 消化管疾患を治療するための医薬組成物
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
CN104016937B (zh) * 2014-05-09 2016-12-07 中科院广州化学有限公司 一种n-芳基氧氮杂卓酮类化合物及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912303D0 (en) * 1989-05-27 1989-07-12 Pfizer Ltd Therapeutic agents
EP0613472A1 (de) * 1991-11-05 1994-09-07 G.D. Searle & Co. 10-acyl-dibenz(b,f)(1,4)-oxazepine und ihre thiazepine analoge verwendbar als prostaglandinantagonisten
WO2002045737A2 (en) * 2000-12-07 2002-06-13 Board Of Regents, The University Of Texas System Methods of treatment involving human mda-7

Also Published As

Publication number Publication date
US6436922B1 (en) 2002-08-20
DE69706406T2 (de) 2002-04-18
EP0889043A4 (de) 1999-07-21
PT889043E (pt) 2002-02-28
EP0889043A1 (de) 1999-01-07
CA2261271C (en) 2003-09-16
DE69706406D1 (de) 2001-10-04
US6127361A (en) 2000-10-03
CA2261271A1 (en) 1997-09-18
TW479057B (en) 2002-03-11
EP0889043B1 (de) 2001-08-29
WO1997033885A1 (en) 1997-09-18
KR100344331B1 (ko) 2002-12-05
ES2159843T3 (es) 2001-10-16
KR19990087655A (ko) 1999-12-27
ZA972038B (en) 1997-09-17
BR9707962A (pt) 1999-07-27
CN1213371A (zh) 1999-04-07
AU2233597A (en) 1997-10-01
NO984162L (no) 1998-11-05
CN1085209C (zh) 2002-05-22
AU704521B2 (en) 1999-04-22
NO310976B1 (no) 2001-09-24
JP3127469B2 (ja) 2001-01-22
NO984162D0 (no) 1998-09-10

Similar Documents

Publication Publication Date Title
DE69604653D1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
BR9811818A (pt) Uso de um composto, composto, e, composição farmacêutica
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
BR9904998A (pt) Derivados de hidroxamida do ácido 5-oxo-pirrolidina-2-carboxìlico
ITRM990338A0 (it) Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria.
ATE227293T1 (de) 2,3-disubstituierte-(5,6)-heteroarylkondensiert - pyrimidin-4-one
TR200001906T2 (tr) Koks-Inhibitörleri olarak 2,3-ikameli indol bileşikleri.
NO20014925L (no) Farmasöytiske forbindelser
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
AU8562198A (en) Remedies for multiple sclerosis
DE69631609D1 (en) Tricyclische erythromycinderivate
ATE204871T1 (de) 5,11-dihydrodibenz b,e 1,4 oxazepin-derivate und diese derivate enthaltende medikamente
NO306116B1 (no) Ny benzotiadiazinforbindelse og farmasöytiske sammensetninger
ES2151698T3 (es) Nuevos derivados de 6-hidroxi y 6-oxo-androstan activos sobre el sistema cardiovascular y composiciones farmaceuticas que los contienen.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ATE140458T1 (de) Imidazole derivate und diese enthaltende arzneimittel
ID25478A (id) Agonis 5-ht1f
EP1073447A4 (de) N1 modifizierte glycopeptide
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
ATE232861T1 (de) 5,11-dihydrobenz(b,e)(1,4)oxazepin-derivate und diese enthaltende medizinische zubereitungen
DE69403110D1 (de) Zyklische Angiopeptin Derivate, deren Herstellung und pharmazeutische Zusammensetzungen
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
EP1142884A4 (de) Oxazepin derivate und drogen die diese enthalten
EP0760375A4 (de) Antitumor-indolopyrolocarbazolderivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee